Trial Outcomes & Findings for Mobile After-Care Support App: Pilot RCT (NCT NCT03955250)

NCT ID: NCT03955250

Last Updated: 2024-03-19

Results Overview

The Client Satisfaction Questionnaire is a self-report measure of patient satisfaction with treatment. The total score (sum of items) will be used and ranges from 8 to 32 with increased scores indicating greater satisfaction with treatment.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

42 participants

Primary outcome timeframe

1 month

Results posted on

2024-03-19

Participant Flow

Participant milestones

Participant milestones
Measure
Mobile After-Care Support (MACS) App
All participants download the app to their mobile phone. The app runs through a third-party software platform. It is designed to provide ecological momentary assessment and intervention. Mobile After-Care Support (MACS) app: The MACS app assesses and intervenes by fostering increased treatment adherence (medication/appointments) and self-coping with illness (active, planned, problem-solving focused) to reduce symptoms and improve functioning.
Mobile App Attention Control
All participants download the app to their mobile phone. The app runs through a third-party software platform. It is designed to provide ecological momentary assessment and psychoeducation about illness. Mobile app attention control: The control app provides ecological momentary assessment and psychoeducation about illness.
Overall Study
STARTED
19
23
Overall Study
COMPLETED
17
16
Overall Study
NOT COMPLETED
2
7

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Mobile After-Care Support App: Pilot RCT

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Mobile After-Care Support (MACS) App
n=19 Participants
All participants download the app to their mobile phone. The app runs through a third-party software platform. It is designed to provide ecological momentary assessment and intervention. Mobile After-Care Support (MACS) app: The MACS app assesses and intervenes by fostering increased treatment adherence (medication/appointments) and self-coping with illness (active, planned, problem-solving focused) to reduce symptoms and improve functioning.
Mobile App Attention Control
n=23 Participants
All participants download the app to their mobile phone. The app runs through a third-party software platform. It is designed to provide ecological momentary assessment and psychoeducation about illness. Mobile app attention control: The control app provides ecological momentary assessment and psychoeducation about illness.
Total
n=42 Participants
Total of all reporting groups
Age, Continuous
32.6 years
STANDARD_DEVIATION 11.7 • n=5 Participants
35.1 years
STANDARD_DEVIATION 11.1 • n=7 Participants
34.3 years
STANDARD_DEVIATION 11.4 • n=5 Participants
Sex: Female, Male
Female
8 Participants
n=5 Participants
8 Participants
n=7 Participants
16 Participants
n=5 Participants
Sex: Female, Male
Male
11 Participants
n=5 Participants
15 Participants
n=7 Participants
26 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
6 Participants
n=5 Participants
4 Participants
n=7 Participants
10 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
13 Participants
n=5 Participants
19 Participants
n=7 Participants
32 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
1 Participants
n=5 Participants
5 Participants
n=7 Participants
6 Participants
n=5 Participants
Race (NIH/OMB)
White
13 Participants
n=5 Participants
13 Participants
n=7 Participants
26 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
5 Participants
n=5 Participants
5 Participants
n=7 Participants
10 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Region of Enrollment
United States
19 participants
n=5 Participants
23 participants
n=7 Participants
42 participants
n=5 Participants

PRIMARY outcome

Timeframe: 1 month

Population: The number of participants analyzed is lower than the number enrolled due to missing data on this measure.

The Client Satisfaction Questionnaire is a self-report measure of patient satisfaction with treatment. The total score (sum of items) will be used and ranges from 8 to 32 with increased scores indicating greater satisfaction with treatment.

Outcome measures

Outcome measures
Measure
Mobile After-Care Support (MACS) App
n=10 Participants
All participants download the app to their mobile phone. The app runs through a third-party software platform. It is designed to provide ecological momentary assessment and intervention. Mobile After-Care Support (MACS) app: The MACS app assesses and intervenes by fostering increased treatment adherence (medication/appointments) and self-coping with illness (active, planned, problem-solving focused) to reduce symptoms and improve functioning.
Mobile App Attention Control
n=12 Participants
All participants download the app to their mobile phone. The app runs through a third-party software platform. It is designed to provide ecological momentary assessment and psychoeducation about illness. Mobile app attention control: The control app provides ecological momentary assessment and psychoeducation about illness.
Client Satisfaction Questionnaire (CSQ)
23.7 score on a scale
Standard Deviation 4.4
22.5 score on a scale
Standard Deviation 7.6

SECONDARY outcome

Timeframe: Baseline, 4 month

Population: This analysis was intent-to-treat based on all participants initially enrolled in the study.

The interviewer-rated Brief Psychiatric Rating Scale is a measure of psychiatric symptom severity. The total score (sum of items) will be used to assess overall severity with scores ranging from 18 to 126 and higher scores indicating greater severity.

Outcome measures

Outcome measures
Measure
Mobile After-Care Support (MACS) App
n=19 Participants
All participants download the app to their mobile phone. The app runs through a third-party software platform. It is designed to provide ecological momentary assessment and intervention. Mobile After-Care Support (MACS) app: The MACS app assesses and intervenes by fostering increased treatment adherence (medication/appointments) and self-coping with illness (active, planned, problem-solving focused) to reduce symptoms and improve functioning.
Mobile App Attention Control
n=23 Participants
All participants download the app to their mobile phone. The app runs through a third-party software platform. It is designed to provide ecological momentary assessment and psychoeducation about illness. Mobile app attention control: The control app provides ecological momentary assessment and psychoeducation about illness.
Brief Psychiatric Rating Scale (BPRS)
Baseline
53.1 score on a scale
Standard Error 2.4
49.8 score on a scale
Standard Error 2.2
Brief Psychiatric Rating Scale (BPRS)
4 Month
36.4 score on a scale
Standard Error 2.6
33.1 score on a scale
Standard Error 2.6

SECONDARY outcome

Timeframe: Baseline, 4 month

Population: This analysis was intent-to-treat based on all participants initially enrolled in the study.

The Brief Adherence Rating Scale assesses the percentage of missed medication doses over the past month. The total adherence score ranges from 0% to 100% and higher scores indicate greater adherence.

Outcome measures

Outcome measures
Measure
Mobile After-Care Support (MACS) App
n=19 Participants
All participants download the app to their mobile phone. The app runs through a third-party software platform. It is designed to provide ecological momentary assessment and intervention. Mobile After-Care Support (MACS) app: The MACS app assesses and intervenes by fostering increased treatment adherence (medication/appointments) and self-coping with illness (active, planned, problem-solving focused) to reduce symptoms and improve functioning.
Mobile App Attention Control
n=23 Participants
All participants download the app to their mobile phone. The app runs through a third-party software platform. It is designed to provide ecological momentary assessment and psychoeducation about illness. Mobile app attention control: The control app provides ecological momentary assessment and psychoeducation about illness.
Brief Adherence Rating Scale (BARS)
Baseline
86.2 units on a scale
Standard Error 4.8
83.8 units on a scale
Standard Error 4.4
Brief Adherence Rating Scale (BARS)
4 Month
94.4 units on a scale
Standard Error 4.9
92.0 units on a scale
Standard Error 4.8

SECONDARY outcome

Timeframe: Baseline, 4 month

Population: This analysis was intent-to-treat based on all participants initially enrolled in the study.

The Brief Cope Inventory is a 28 item self-report measure of coping skills. The mean values of the 12-item dysfunctional coping subscale was used. Mean scores for the total range from 1-48 with higher scores indicating greater use of the dysfunctional coping strategies.

Outcome measures

Outcome measures
Measure
Mobile After-Care Support (MACS) App
n=19 Participants
All participants download the app to their mobile phone. The app runs through a third-party software platform. It is designed to provide ecological momentary assessment and intervention. Mobile After-Care Support (MACS) app: The MACS app assesses and intervenes by fostering increased treatment adherence (medication/appointments) and self-coping with illness (active, planned, problem-solving focused) to reduce symptoms and improve functioning.
Mobile App Attention Control
n=23 Participants
All participants download the app to their mobile phone. The app runs through a third-party software platform. It is designed to provide ecological momentary assessment and psychoeducation about illness. Mobile app attention control: The control app provides ecological momentary assessment and psychoeducation about illness.
Brief Cope Inventory (Brief COPE)
Baseline
28.6 score on a scale
Standard Error 1.6
28.1 score on a scale
Standard Error 1.5
Brief Cope Inventory (Brief COPE)
4 Month
24.8 score on a scale
Standard Error 1.7
24.4 score on a scale
Standard Error 1.7

Adverse Events

Mobile After-Care Support (MACS) App

Serious events: 11 serious events
Other events: 0 other events
Deaths: 0 deaths

Mobile App Attention Control

Serious events: 9 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
Mobile After-Care Support (MACS) App
n=19 participants at risk
All participants download the app to their mobile phone. The app runs through a third-party software platform. It is designed to provide ecological momentary assessment and intervention. Mobile After-Care Support (MACS) app: The MACS app assesses and intervenes by fostering increased treatment adherence (medication/appointments) and self-coping with illness (active, planned, problem-solving focused) to reduce symptoms and improve functioning.
Mobile App Attention Control
n=23 participants at risk
All participants download the app to their mobile phone. The app runs through a third-party software platform. It is designed to provide ecological momentary assessment and psychoeducation about illness. Mobile app attention control: The control app provides ecological momentary assessment and psychoeducation about illness.
Psychiatric disorders
Rehospitalization
47.4%
9/19 • 4 months
39.1%
9/23 • 4 months
Psychiatric disorders
Suicide attempt
10.5%
2/19 • 4 months
0.00%
0/23 • 4 months

Other adverse events

Adverse event data not reported

Additional Information

Brandon Gaudiano, Ph.D.

Butler Hospital

Phone: 401-455-6457

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place